Home › NDC Lookup › Ingredients › Lanadelumab-Flyo
📦 NDC / package directory — not a drug information page

Lanadelumab-Flyo NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Lanadelumab-Flyo products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Looking for uses, warnings & side effects? Read our Lanadelumab-Flyo drug information page →

Key stats

5
Package NDCs
9
Products
9
Active listings
0
Discontinued
3
Labelers
3
Strengths
2
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
LANADELUMAB 300 mg/2mL 5
LANADELUMAB 150 mg/mL 3
LANADELUMAB 300 mg/2.25mL 1
By dosage form
SOLUTION 6
INJECTION, SOLUTION 3
Top labelers
Takeda Pharmaceuticals America, In... 7
Rentschler Biopharma SE 1
Catalent Indiana, LLC 1

Browse records — 9 products

Drug / product Billing NDC NADAC / unit Status
Lanadelumab-flyo 300 mg/2mL INJECTION, SOLUTION Rentschler · NDC 64538-0644-00 · 5 mL in 1 VIAL, GLASS (64538-644-00) 64538-0644-00 — FDA-listed View →
lanadelumab-flyo 300 mg/2.25mL INJECTION, SOLUTION Catalent · NDC 61434-0019-02 · 560 VIAL in 1 CASE (61434-019-02) / 2.25 mL in 1 VIAL 61434-0019-02 — FDA-listed View →
TAKHZYRO lanadelumab-flyo 300 mg/2mL INJECTION, SOLUTION Takeda · NDC 47783-0644-01 · 1 VIAL, GLASS in 1 CARTON (47783-644-01) / 5 mL in 1 VIAL, GLASS 47783-0644-01 — Discontinued View →
TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION Takeda · NDC 47783-0645-01 · J0593 · 1 SYRINGE, GLASS in 1 CARTON (47783-645-01) / 1 mL in 1 SYRINGE, GLASS 47783-0645-01 — FDA-listed View →
TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION Takeda · NDC 47783-0646-01 · J0593 · 1 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS 47783-0646-01 — FDA-listed View →
TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION Takeda · NDC 47783-0646-01 · J0593 · 1 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS 47783-0646-01 — FDA-listed View →
TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION Takeda · NDC 47783-0645-01 · J0593 · 1 SYRINGE, GLASS in 1 CARTON (47783-645-01) / 1 mL in 1 SYRINGE, GLASS 47783-0645-01 — FDA-listed View →
TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION Takeda · NDC 47783-0645-01 · J0593 · 1 SYRINGE, GLASS in 1 CARTON (47783-645-01) / 1 mL in 1 SYRINGE, GLASS 47783-0645-01 — FDA-listed View →
TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION Takeda · NDC 47783-0646-01 · J0593 · 1 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS 47783-0646-01 — FDA-listed View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.